← FDA Drug Approvals (Drugs@FDA)
METHAZOLAMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TAGI · Approved 2022-10-18
Drug application
- FDA Application #
ANDA215615
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- METHAZOLAMIDE
- Generic name
- METHAZOLAMIDE
- Active ingredients
- METHAZOLAMIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- TAGI
- Manufacturer
- Precision Dose, Inc.
- First approval
- 2022-10-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown